Paper41008319
Neuropsychiatric Symptoms in Cerebral Amyloid Angiopathy: A Significant but Overlooked Association.
Rus Prelog P and 2 others. Brain Sci, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Neuropsychiatric Symptoms in Cerebral Amyloid Angiopathy: A Significant but Overlooked Association. Papers, record 41008319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008319
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neuropsychiatric Symptoms in Cerebral Amyloid Angiopathy: A Significant but Overlooked Association.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38362804 | Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy. | J Neurochem | 2024 | https://conductscience.org/library/papers/38362804 | PubMed |
| 2 | 40201593 | Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy-confirmed cohort from China. | Alzheimers Dement (Amst) | 2025 | https://conductscience.org/library/papers/40201593 | PubMed |
| 3 | 28993004 | Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern. | Rev Neurol (Paris) | 2017 | https://conductscience.org/library/papers/28993004 | PubMed |
| 4 | 26537052 | Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. | Neurology | 2015 | https://conductscience.org/library/papers/26537052 | PubMed |
| 5 | 28844070 | The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. | J Neurol Neurosurg Psychiatry | 2017 | https://conductscience.org/library/papers/28844070 | PubMed |
| 6 | 40343697 | Cerebral Amyloid Angiopathy and Downstream Alzheimer Disease Plasma Biomarkers. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40343697 | PubMed |
| 7 | 39308134 | Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross-sectional study. | Eur J Neurol | 2024 | https://conductscience.org/library/papers/39308134 | PubMed |
| 8 | 33547125 | Successful electroconvulsive therapy for depression in a man with cerebral amyloid angiopathy. | BMJ Case Rep | 2021 | https://conductscience.org/library/papers/33547125 | PubMed |
| 9 | 40118715 | Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/40118715 | PubMed |
| 10 | 38306032 | Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease. | J Alzheimers Dis | 2024 | https://conductscience.org/library/papers/38306032 | PubMed |
| 11 | 35841910 | The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/35841910 | PubMed |
| 12 | 34587793 | Cerebral Small Vessel Disease and Depression Among Intracerebral Hemorrhage Survivors. | Stroke | 2022 | https://conductscience.org/library/papers/34587793 | PubMed |
| 13 | 37236210 | Progression of cerebral amyloid angiopathy: a pathophysiological framework. | Lancet Neurol | 2023 | https://conductscience.org/library/papers/37236210 | PubMed |
| 14 | 39232823 | Neuropsychiatric symptoms and lifelong mental activities in cerebral amyloid angiopathy - a cross-sectional study. | Alzheimers Res Ther | 2024 | https://conductscience.org/library/papers/39232823 | PubMed |
| 15 | 35171235 | Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias. | JAMA Psychiatry | 2022 | https://conductscience.org/library/papers/35171235 | PubMed |
| 16 | 38020625 | Risk factors for recurrent cerebral amyloid angiopathy-related intracerebral hemorrhage. | Front Neurol | 2023 | https://conductscience.org/library/papers/38020625 | PubMed |
| 17 | 34877794 | A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment. | Alzheimers Dement | 2022 | https://conductscience.org/library/papers/34877794 | PubMed |
| 18 | 37587609 | Antidepressants and the risk of bleeding in the era of anti-amyloid drugs. | Alzheimers Dement | 2023 | https://conductscience.org/library/papers/37587609 | PubMed |
| 19 | 38388894 | Cognitive and psychological characteristics in patients with Cerebral Amyloid Angiopathy: a literature review. | Neurol Sci | 2024 | https://conductscience.org/library/papers/38388894 | PubMed |
| 20 | 39387105 | Cognition in (pre)symptomatic Dutch-type hereditary and sporadic cerebral amyloid angiopathy. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/39387105 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41008319
GET https://conductscience.org/api/papers/v1/41008319/references?page=2